HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cora N Sternberg Selected Research

satraplatin (JM 216)

1/2012An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.
1/2012Clinical and pharmacokinetic evaluation of satraplatin.
11/2009Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.
9/2009Satraplatin for the therapy of castration-resistant prostate cancer.
11/2005Satraplatin in the treatment of hormone-refractory prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cora N Sternberg Research Topics

Disease

108Prostatic Neoplasms (Prostate Cancer)
07/2022 - 08/2002
72Neoplasms (Cancer)
07/2022 - 06/2003
53Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 06/2003
39Carcinoma (Carcinomatosis)
01/2022 - 02/2002
34Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 01/2002
33Neoplasm Metastasis (Metastasis)
01/2022 - 10/2002
21Disease Progression
01/2022 - 08/2002
16Pain (Aches)
07/2022 - 11/2005
13Fatigue
01/2022 - 03/2011
10Hypertension (High Blood Pressure)
08/2019 - 03/2011
7Neutropenia
01/2022 - 06/2009
7Transitional Cell Carcinoma
09/2010 - 02/2002
6Diarrhea
06/2022 - 09/2012
5Kidney Neoplasms (Kidney Cancer)
11/2018 - 06/2003
4Urologic Neoplasms (Urological Cancer)
10/2020 - 07/2010
3Asthenia
10/2021 - 12/2014
3Bone Diseases (Bone Disease)
01/2018 - 12/2009
3Clear-cell metastatic renal cell carcinoma
06/2015 - 08/2013
3Thrombocytopenia (Thrombopenia)
01/2015 - 08/2013
2Urinary Tract Infections (Urinary Tract Infection)
06/2022 - 01/2021
2Microsatellite Instability
11/2021 - 01/2021
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2021 - 11/2009
2Pneumonia (Pneumonitis)
10/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

33enzalutamideIBA
03/2022 - 05/2012
33Docetaxel (Taxotere)FDA Link
01/2022 - 01/2004
26Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2002
24PlatinumIBA
01/2022 - 08/2002
23pazopanibFDA Link
12/2021 - 02/2008
22AndrogensIBA
01/2022 - 02/2007
21Hormones (Hormone)IBA
07/2022 - 08/2002
18Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 12/2008
13Androgen Receptors (Androgen Receptor)IBA
01/2022 - 09/2012
12abirateroneIBA
01/2022 - 05/2011
12Sunitinib (Sutent)FDA Link
12/2021 - 02/2008
12Prednisone (Sone)FDA LinkGeneric
12/2020 - 09/2009
11Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2010
11Biological ProductsIBA
12/2021 - 10/2002
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2019 - 02/2005
10Abiraterone AcetateIBA
08/2019 - 05/2011
9Pharmaceutical PreparationsIBA
01/2021 - 03/2008
9Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2008
8Immune Checkpoint InhibitorsIBA
12/2021 - 01/2019
8GemcitabineFDA Link
01/2020 - 06/2003
7Sorafenib (BAY 43-9006)FDA Link
11/2018 - 02/2008
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2019
6Radium-223IBA
01/2022 - 05/2012
6pembrolizumabIBA
01/2022 - 01/2017
5LigandsIBA
01/2022 - 02/2014
5Angiogenesis InhibitorsIBA
12/2021 - 03/2010
5Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2020
5cabazitaxelFDA Link
10/2021 - 05/2012
5atezolizumabIBA
09/2021 - 01/2019
5DenosumabFDA Link
01/2019 - 05/2011
5CytokinesIBA
04/2013 - 09/2009
5satraplatin (JM 216)IBA
01/2012 - 11/2005
4avelumabIBA
06/2022 - 01/2020
4RamucirumabIBA
01/2022 - 11/2017
4taxaneIBA
10/2021 - 02/2007
4EverolimusFDA Link
03/2019 - 07/2016
4Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 09/2002
4Vinblastine (Vinblastine Sulfate)FDA Link
01/2018 - 09/2002
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 09/2002
4Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 06/2003
3rucaparibIBA
12/2021 - 11/2020
3Carboplatin (JM8)FDA LinkGeneric
06/2021 - 01/2018
3NivolumabIBA
01/2019 - 01/2019
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018 - 03/2011
3Diphosphonates (Bisphosphonates)IBA
07/2018 - 02/2007
3Zoledronic Acid (Zometa)FDA Link
01/2016 - 05/2011
3Hemoglobins (Hemoglobin)IBA
06/2015 - 04/2013
3Proteins (Proteins, Gene)FDA Link
09/2012 - 03/2010
3VaccinesIBA
05/2011 - 03/2010
2darolutamideIBA
07/2022 - 01/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022 - 01/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 01/2022
2Metformin (Glucophage)FDA LinkGeneric
01/2022 - 01/2022
2Monoclonal AntibodiesIBA
01/2022 - 01/2019
2sacituzumab govitecanIBA
12/2021 - 01/2021
2Cell-Free Nucleic AcidsIBA
11/2021 - 12/2016
2Prednisolone (Predate)FDA LinkGeneric
10/2021 - 12/2020
2Etoposide (VP 16)FDA LinkGeneric
10/2021 - 10/2021
2Testosterone (Sustanon)FDA Link
12/2020 - 03/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2020 - 06/2009

Therapy/Procedure

105Therapeutics
07/2022 - 02/2002
83Castration
07/2022 - 03/2008
81Drug Therapy (Chemotherapy)
06/2022 - 08/2002
15Combination Drug Therapy (Combination Chemotherapy)
12/2021 - 06/2003
15Cystectomy
01/2021 - 02/2002
11Adjuvant Chemotherapy
12/2020 - 12/2005
11Neoadjuvant Therapy
10/2020 - 04/2003
9Immunotherapy
06/2022 - 02/2002
6Nephrectomy
01/2021 - 07/2010
4Radiotherapy
01/2022 - 01/2007
4Aftercare (After-Treatment)
01/2022 - 01/2017
4Palliative Care (Palliative Therapy)
01/2012 - 10/2008
3Lymph Node Excision (Lymph Node Dissection)
01/2021 - 01/2015
3Molecular Targeted Therapy
01/2018 - 08/2002
3Prostatectomy (Retropubic Prostatectomy)
10/2013 - 08/2002
2Precision Medicine
01/2022 - 02/2017
2Urinary Diversion (Ileal Conduit)
12/2020 - 10/2002